Profile data is unavailable for this security.
About the company
Flora Growth Corp. operates as a lifestyle brand in the United States and international pharmaceutical distributor focused on therapeutics, starting with medical cannabis. The Company serves approximately 50 states and 28 countries. The Company’s JustCBD is a consumer-packaged goods brand. JustCBD. JustCBD offering consists of over 350 products across 15 categories, including cannabidiol (CBD) gummies, topicals, tinctures, and vape products. JustCBD products are available for purchase in smoke and vape shops, clinics, spas, and pet stores, as well as other independent non-traditional retail channels. The Company’s Vessel is a cannabis accessory and technology brand servicing the United States and Canada through direct-to-consumer and retail sales. Vessel's products include cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herb categories, which are sold to consumers, dispensaries, smoke shops and cannabis brands.
- Revenue in USD (TTM)76.07m
- Net income in USD-47.36m
- Incorporated2019
- Employees97.00
- LocationFlora Growth Corp3406 SW 26th TERRACE, SUITE C-1FORT LAUDERDALE 33312United StatesUSA
- Phone+1 (416) 861-2267
- Websitehttps://www.floragrowth.com/
More ▼
Mergers & acquisitions
| Acquired company | FLGC:NAQ since announced | Transaction value |
|---|---|---|
| Australian Vaporizers Pty Ltd | -39.43% | 1.90m |
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor Therapeutics Inc | 0.00 | -3.03m | 20.30m | 3.00 | -- | 3.84 | -- | -- | -0.0176 | -0.0176 | 0.00 | 0.0307 | 0.00 | -- | -- | 0.00 | -28.92 | 27.48 | -30.91 | 32.70 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -125.39 | -- | -- | -- |
| CERo Therapeutics Holdings Inc | 0.00 | -2.54m | 20.32m | 8.00 | -- | -- | -- | -- | -0.3796 | -0.3796 | 0.00 | -0.9226 | 0.00 | -- | -- | 0.00 | -9.96 | -- | -33.80 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -279.82 | -- | -- | -- |
| MEI Pharma Inc | 72.65m | 19.84m | 20.39m | 46.00 | 1.03 | 0.3427 | 1.01 | 0.2807 | 2.98 | 2.98 | 10.90 | 8.93 | 0.6425 | -- | 25.47 | 1,579,304.00 | 17.55 | -25.31 | 20.31 | -28.59 | -- | -- | 27.32 | -122.05 | -- | -- | 0.00 | -- | 19.95 | 97.56 | 41.53 | -- | -- | -- |
| Evaxion Biotech A/S - ADR | 73.00k | -22.13m | 20.60m | 49.00 | -- | -- | -- | 282.18 | -81.29 | -81.29 | 0.2665 | -1.25 | 0.0042 | -- | 0.091 | 1,489.80 | -126.74 | -100.11 | -183.85 | -131.65 | -- | -- | -30,308.22 | -131,560.30 | -- | -30.92 | 1.77 | -- | -- | -- | 4.51 | -- | 65.53 | -- |
| AIM ImmunoTech Inc | 202.00k | -28.96m | 20.60m | 26.00 | -- | 2.08 | -- | 101.98 | -0.595 | -0.595 | 0.0042 | 0.2084 | 0.0068 | -- | 0.1413 | 7,769.23 | -96.75 | -45.64 | -116.18 | -48.35 | 79.21 | -231.75 | -14,337.62 | -11,695.01 | -- | -- | 0.00 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
| Serina Therapeutics Inc | 142.00k | -14.80m | 20.76m | 4.00 | -- | 1.64 | -- | 146.17 | -13.72 | -13.72 | 0.1316 | 5.07 | 0.0187 | -- | 4.66 | 35,500.00 | -194.80 | -194.46 | -- | -- | 71.83 | 85.80 | -10,430.28 | -2,347.36 | -- | -2.03 | 0.4489 | -- | 317.65 | -36.69 | -41.49 | -- | -- | -- |
| Alaunos Therapeutics Inc | 5.00k | -35.14m | 20.82m | 1.00 | -- | 3.30 | -- | 4,163.25 | -2.20 | -2.20 | 0.0003 | 0.3939 | 0.0001 | -- | 2.00 | 5,000.00 | -96.01 | -74.83 | -149.28 | -89.57 | -- | -- | -702,800.00 | -10,508.06 | -- | -14.83 | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 20.84m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| Biomx Inc | 0.00 | -26.17m | 21.20m | 58.00 | -- | 5.73 | -- | -- | -0.5433 | -0.5433 | 0.00 | 0.067 | 0.00 | -- | -- | 0.00 | -74.18 | -- | -101.74 | -- | -- | -- | -- | -- | -- | -21.95 | 0.7841 | -- | -- | -- | 7.59 | -- | -- | -- |
| Synlogic Inc | 3.37m | -57.28m | 21.43m | 6.00 | -- | 0.3963 | -- | 6.36 | -11.41 | -11.41 | 0.6581 | 4.64 | 0.0362 | -- | -- | 561,833.30 | -61.46 | -40.57 | -74.45 | -43.82 | -- | -- | -1,699.26 | -3,245.93 | -- | -- | 0.00009 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
| Flora Growth Corp | 76.07m | -47.36m | 21.67m | 97.00 | -- | 2.36 | -- | 0.2848 | -6.62 | -7.97 | 10.04 | 0.7167 | 1.45 | 6.76 | 31.13 | 784,237.10 | -89.22 | -- | -130.91 | -- | 23.32 | -- | -61.35 | -- | 0.7897 | -- | 0.2317 | -- | 127.75 | -- | -1.87 | -- | -- | -- |
| TherapeuticsMD Inc | 1.30m | -7.70m | 21.68m | 1.00 | -- | 0.7403 | -- | 16.65 | -0.7466 | -1.00 | 0.1249 | 2.54 | 0.0195 | -- | -- | 1,302,000.00 | -11.51 | -53.35 | -19.23 | -111.61 | 100.00 | 86.67 | -591.32 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| OncoCyte Corp | 1.50m | -25.80m | 22.01m | 43.00 | -- | 1.07 | -- | 14.64 | -3.08 | -3.47 | 0.1869 | 3.10 | 0.0172 | -- | 1.20 | 34,953.49 | -28.41 | -35.11 | -31.93 | -39.71 | 27.48 | -- | -1,653.69 | -2,373.36 | -- | -146.07 | 0.00 | -- | 56.89 | -- | -34.84 | -- | 55.41 | -- |
| NRX Pharmaceuticals Inc | 0.00 | -30.16m | 22.02m | 2.00 | -- | -- | -- | -- | -2.95 | -2.95 | 0.00 | -0.1398 | 0.00 | -- | -- | -- | -182.00 | -120.57 | -- | -168.40 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.14 | -- | -- | -- |
| Zivo Bioscience Inc | 27.65k | -7.78m | 22.14m | 8.00 | -- | -- | -- | 800.85 | -4.62 | -4.62 | 0.0163 | -0.9259 | 0.0206 | -- | -- | 3,456.25 | -580.66 | -376.60 | -- | -- | 41.99 | -- | -28,127.23 | -96,315.32 | -- | -97.39 | -- | -- | -- | -- | 11.07 | -- | -- | -- |
| Cumberland Pharmaceuticals, Inc. | 39.55m | -6.28m | 22.40m | 91.00 | -- | 0.7537 | -- | 0.5663 | -0.4448 | -0.4448 | 2.75 | 2.10 | 0.4528 | 0.8383 | 3.45 | 434,643.10 | -7.25 | -7.03 | -10.66 | -9.52 | 84.66 | 79.95 | -16.01 | -17.64 | 1.11 | -25.08 | 0.3041 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
Data as of May 03 2024. Currency figures normalised to Flora Growth Corp's reporting currency: US Dollar USD
13.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Global X Management Co. LLCas of 31 Dec 2023 | 988.37k | 12.04% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 60.61k | 0.74% |
| Geode Capital Management LLCas of 31 Dec 2023 | 36.30k | 0.44% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 16.99k | 0.21% |
| XTX Markets LLCas of 31 Dec 2023 | 12.21k | 0.15% |
| Tower Research Capital LLCas of 31 Dec 2023 | 6.37k | 0.08% |
| UBS Securities LLCas of 31 Dec 2023 | 2.07k | 0.03% |
| RBC Dominion Securities, Inc. (Investment Management)as of 31 Dec 2023 | 749.00 | 0.01% |
| UBS Financial Services, Inc.as of 31 Dec 2023 | 486.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2023 | 421.00 | 0.01% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
